Rome: The Italian Government acknowledges and accepts the outcome of the test aimed at verifying EU banks’ capital adequacy with respect to possible adverse economic developments (stress test), carried out within the EU by competent national authorities and the Committee of European Banking Supervisors (CEBS), in close connection with the European Central Bank and the European Commission.
The Italian Government welcomes the enhanced transparency that has been achieved with the publication of these results.
The results of the stress test carried out with reference to five big Italian banking groups show their capital adequacy and resilience, even in the most adverse and less likely scenarios.
The Member States and the European Commission, in order to preserve market trust, have agreed on the need to set up or maintain national schemes which would allow public financial support for the concerned financial intermediaries, where necessary.
In line and pursuant to this EU policy, although there is no element which indicates that Italian banking groups might need it, the Italian Government will anyway re-open the timeframe that would allow the Italian Government, if ever needed, to subscribe the financial instruments issued pursuant to art. 12 of the law decree 29 November 2008, n. 185.
Ultimi Articoli
PMI e Intelligenza Artificiale, il nodo è il metodo: senza regole l’innovazione resta apparente
San Siro, debutto con Sfera Ebbasta: parcheggio bici gratuito e custodito per i concerti di luglio
Teatro Menotti in Sormani: un mese di teatro, musica e grandi protagonisti
Serena Sinigaglia lascia il Teatro Carcano: dal 2027 al 2029 guiderà la Fondazione Teatri di Pistoia
Il Premio Strega 2026 arriva in tutta Roma con la finale in Campidoglio
Crans-Montana, Regione Lombardia ieri si è costituita parte civile per il rogo del locale Le Constellation
Coca-Cola Pizza Village 2026, a Pozzuoli sei giorni tra pizzerie, musica e incontri
IPRN Awards 2026, i trofei firmati Università di Parma tra AI e design
FDA approva la prima terapia genica per bambini con anemia falciforme dai 2 anni